A.M. Palache

4.8k citations

59 papers · 3.5k · h-index 33

Impact in

Epidemiology top 0.5%
- Influenza Virus Research Studies
- Respiratory viral infections research
Immunology top 2%
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction

Papers in

Epidemiology 50
- Influenza Virus Research Studies 50
- Respiratory viral infections research 22
Infectious Diseases 15
- SARS-CoV-2 and COVID-19 Research 9

Co-authors: W.E.P. Beyer (14 shared papers)Albert D. M. E. Osterhaus (9 shared papers)J.C. de Jong (4 shared papers)N. Masurel (6 shared papers)Guus F. Rimmelzwaan (4 shared papers)Jan Wilschut (10 shared papers)Iris A. de Bruijn (6 shared papers)G.J.M. van Scharrenburg (6 shared papers)
Journals: Vaccine (29 papers)Virus Research (3 papers)Annals of the Rheumatic Diseases (2 papers)Journal of Medical Virology (2 papers)PharmacoEconomics (1 paper)
Partner nations: Netherlands Belgium Switzerland

In The Last Decade

A.M. Palache

58 papers receiving 3.3k citations

Peers

Replace Changgui Li with:

Changgui Li China

Joshua G. Petrie United States

Katja Höschler United Kingdom

Christopher S. Ambrose United States

Nadine Rouphael United States

Nicholas S. Kelley United States

Natalie Pica United States

Fernando P. Polack United States

Fatima Amanat United States

Aneesh K. Mehta United States

A.M. Palache relative to Changgui Li China Changgui Li's profile →

Citations per field

00.5×1.5×1.9×

Changgui Li · 1×

×1.9 3k/1k

EPIDE

×1.8 946/516

IMMUN

×0.4 640/2k

ID

×0.7 274/393

HEALT

×1.1 141/127

MS

Citations per year

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

'26

Countries citing papers authored by A.M. Palache

Since Specialization

Citations

This map shows the geographic impact of A.M. Palache's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Palache with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Palache more than expected).

Fields of papers citing papers by A.M. Palache

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Palache. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Palache. The network helps show where A.M. Palache may publish in the future.

Co-authors

The 25 scholars most cited alongside A.M. Palache, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A.M. Palache Line = papers co-authored together A.M. Palache links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Haemagglutination-inhibiting antibody to influenza virus. PubMed ·J.C. de Jong, A.M. Palache, W.E.P. Beyer, Guus F. Rimmelzwaan, Adrianus C. M. Boon, Albert D. M. E. Osterhaus	2003	269
2	Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy Vaccine ·W.E.P. Beyer, A.M. Palache, J.C. de Jong, Albert D. M. E. Osterhaus	2002	200
3	Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly Journal of Medical Virology ·J.C. de Jong, W.E.P. Beyer, A.M. Palache, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus	2000	196
4	The virosome concept for influenza vaccines Vaccine ·Anke Huckriede, Laura Bungener, Toon Stegmann, Toos Daemen, (unknown), A.M. Palache, Jan Wilschut	2005	190
5	Antibody induction by influenza vaccines in the elderly: a review of the literature Vaccine ·W.E.P. Beyer, A.M. Palache, Machteld Baljet, N. Masurel	1989	169
6	Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries Vaccine ·G VANESSEN, A.M. Palache, Eduardo Forleo, David S. Fedson	2003	159
7	Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Research ·W.E.P. Beyer, A.M. Palache, Guido Lüchters, J. J. P. Nauta, Albert D. M. E. Osterhaus	2004	145
8	Protection Against Influenza After Annually Repeated Vaccination Archives of Internal Medicine ·W.E.P. Beyer, Iris A. de Bruijn, A.M. Palache, Ruud G. J. Westendorp, Albert Osterhaus	1999	144
9	Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial The Lancet ·Iain Stephenson, Karl G. Nicholson, Reinhardt Glück, Robert Mischler, Robert W. Newman, A.M. Palache, Neville Q. Verlander, Fiona Warburton, John Wood, Maria Zambon	2003	125
10	Annual public health and economic benefits of seasonal influenza vaccination: a European estimate BMC Public Health ·E. Préaud, Laure Durand, Bérengère Macabeo, Norbert Farkas, Brigitte Sloesen, A.M. Palache, Francis Shupo, Sandrine Samson	2014	120
11	Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults Vaccine ·W.E.P. Beyer, A.M. Palache, M Sprenger, Eva Hendriksen, J.J. Tukker, Roger Darioli, G.L. van der Water, N. Masurel, Albert D. M. E. Osterhaus	1996	109
12	Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity Vaccine ·Lolke de Haan, Willem R. Verweij, Marijke Holtrop, Ruud Brands, G.J.M. van Scharrenburg, A.M. Palache, Etienne Agsteribbe, Jan Wilschut	2001	108
13	Immunogenicity and Reactogenicity of Influenza Subunit Vaccines Produced in MDCK Cells or Fertilized Chicken Eggs The Journal of Infectious Diseases ·A.M. Palache, Ruud Brands, G.J.M. van Scharrenburg	1997	90
14	Seasonal influenza vaccine dose distribution in 195 countries (2004–2013): Little progress in estimated global vaccination coverage Vaccine ·A.M. Palache, Valérie Oriol-Mathieu, Mireli Fino, Margarita Xydia-Charmanta	2015	84
15	Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents and young volunteers Vaccine ·A.M. Palache, W.E.P. Beyer, M Sprenger, N. Masurel, S. De Jonge, A. Vardy, B Charpentier, J. Noury, W.C.A. van Beek, Rowie Borst, Gerard J. Ligthart, G. Keren, Eitan Rubinstein	1993	83
16	Influenza Vaccines Drugs ·A.M. Palache	1997	80
17	Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes Vaccine ·Aalzen de Haan, H.J. Geerligs, J. P. Huchshorn, G.J.M. van Scharrenburg, A.M. Palache, Jan Wilschut	1995	78
18	Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies European Journal of Clinical Microbiology & Infectious Diseases ·W.E.P. Beyer, A.M. Palache, René Kerstens, N. Masurel	1996	73
19	Seasonal influenza vaccine provision in 157 countries (2004–2009) and the potential influence of national public health policies Vaccine ·A.M. Palache	2011	72
20	Immunogenicity and safety of inactivated influenza vaccines in primed populations: A systematic literature review and meta-analysis Vaccine ·W.E.P. Beyer, J. J. P. Nauta, A.M. Palache, Katinka Giezeman, A.D.M.E. Osterhaus	2011	62

About A.M. Palache

A.M. Palache is a scholar working on Epidemiology, Infectious Diseases, Immunology, Molecular Biology and Health, having authored 59 papers that have together received 3.5k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (50 papers), Respiratory viral infections research (22 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Vaccine Coverage and Hesitancy (8 papers), COVID-19 epidemiological studies (8 papers), Immunotherapy and Immune Responses (6 papers), Immune Response and Inflammation (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Epidemiology (2.6k citations), Immunology (946 citations), Infectious Diseases (640 citations), Health (274 citations) and Modeling and Simulation (141 citations). A.M. Palache has collaborated with scholars based in Netherlands, Belgium and Switzerland. Frequent co-authors include W.E.P. Beyer, Albert D. M. E. Osterhaus, J.C. de Jong, N. Masurel, Guus F. Rimmelzwaan, Jan Wilschut, Iris A. de Bruijn, G.J.M. van Scharrenburg, J. J. P. Nauta and Ruud Brands. Their work appears in journals such as Vaccine, Virus Research, Annals of the Rheumatic Diseases, Journal of Medical Virology and PharmacoEconomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

A.M. Palache

Impact in

Papers in i

In The Last Decade

A.M. Palache

Peers

Countries citing papers authored by A.M. Palache

Fields of papers citing papers by A.M. Palache

All Works

About A.M. Palache

Explore authors with similar magnitude of impact

Papers in